First reported case of delayed‐type hypersensitivity reaction to non‐hyaluronic acid Polycaprolactone dermal filler following COVID‐19 vaccination: A case report and a review of the literature
Yasamin Kalantari, Afsaneh Sadeghzadeh‐Bazargan, Zeinab Aryanian, Parvaneh Hatami, Azadeh Goodarzi
Abstract
Cases of filler reactions after COVID-19 vaccination have been reported. Here, we present the first case of delayed-type reaction (DTR) to non-hyaluronic acid Polycaprolactone dermal filler after the second dose of Sinopharm COVID-19 vaccine which was improved with administration of topical and intralesional steroids.
Topics & Concepts
MedicineHyaluronic acidFiller (materials)PolycaprolactoneCoronavirus disease 2019 (COVID-19)VaccinationHypersensitivity reactionDermatologySurgeryImmunologyInternal medicineComposite materialDiseaseMaterials sciencePolymerInfectious disease (medical specialty)AnatomyDermatological and COVID-19 studiesIntramuscular injections and effectsSkin Diseases and Diabetes